Med Gen Completes Claims Substantiation and Support Documents for UnDiet(TM) System.

BOCA RATON, Fla. -- Med Gen Inc. (OTCBB:MGEN), manufacturers of nationally branded OTC healthier life products, announced that it has fully completed the documentation to support the underlying claims made to support its weight loss program, UnDiet[TM] System.

As a precursor to its investment in TV and Print advertising programs, Med Gen has completed a thorough study to support any claims it makes regarding the weight loss program the company hopes will contribute significantly to its revenues and earnings this year. The study is complete with support information, Certificates of Analysis, product descriptions, mechanisms of action, special features, confirmation of special research, pharmacology and therapeutics. Of great importance is Med Gen's use of premium quality ingredients and of the much heralded Hoodia (in liquid form) and Citrin[R] ("Natures Own Effective Weight Loss Agent") manufactured by Sabinsa Corporation for Med Gen. The use of Citrin[R] is thoroughly discussed in documentation that will soon be published on the www.undietsystem.com, the company's product web site.

Med Gen management believes that UnDiet[TM], a unique weight loss system featuring the company's STW[R] spray system will quickly become the "diet of choice" for the millions now seeking the miracle weight loss product. "It's cost efficient, easy to use and best of all it works," said Mr. Mitchell, President. Testimonials as to the efficacy of UnDiet[TM] are received daily, Mr. Mitchell added.

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray's the Way ("STW"). It is best known for producing the world's first patented liquid spray snoring relief formula, Snorenz[R]. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep[R] and the Un-Diet[TM] system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names.

Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol "MGEN". For information contact Investor Relations 561-750-1100 or www.medgen.com.

This Press Release contains or incorporates by reference "forward-looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward-looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward-looking statements.